Sandoz

Sandoz develops, manufactures and markets generic pharmaceutical products focused on biosimilars, injectables, inhalers and transdermal patches. Read more

Richard Saynor's photo - CEO of Sandoz

CEO

Richard Saynor

CEO Approval Rating

70/100

Founded:

1886

Status:

PrivateSubsidiary of Novartis AG.

Est. Annual Revenue
Est. Employees

SANDOZ TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Par Pharmaceutical is perceived as one of Sandoz's biggest rivals. Par Pharmaceutical was founded in 1978, and is headquartered in Chestnut Ridge, New York. Like Sandoz, Par Pharmaceutical also competes in the Pharmaceuticals space. Par Pharmaceutical generates $8.9B less revenue vs. Sandoz.

Ranbaxy is a top competitor of Sandoz. Ranbaxy is a Private company that was founded in 1961 in New Delhi, Delhi. Like Sandoz, Ranbaxy also works within the Pharmaceuticals sector. Compared to Sandoz, Ranbaxy has 11,200 fewer employees.

Sagent Pharmaceuticals is Sandoz's #3 rival. Sagent Pharmaceuticals is headquartered in Schaumburg, Illinois, and was founded in 2006. Sagent Pharmaceuticals operates in the Pharmaceuticals industry. Sagent Pharmaceuticals generates 3.09% the revenue of Sandoz.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Sanofi a competitor of Sandoz?

Sandoz Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Cephalosporin Antibiotics Business, GlaxoSmithKline plc.

Feb 2021

Source »
$350M
-

-

Japanese Business, Aspen Global Incorporated

Nov 2019

Source »
$330.5M
-
AmLactin

Dec 2016

Source »
undisclosed
AmLactin is a developer, manufacturer and marketer of skin care products including therapeutic moisturizers and conditioners.

-

EBEWE Pharma

Sep 2009

Source »
$1.3B
-

These are all the companies that Sandoz has acquired. Sandoz has acquired 4 companies and its latest acquisition was Cephalosporin Antibiotics Business, GlaxoSmithKline plc. in Feb 2021.

Sandoz Funding History

No recent funding data found related to Sandoz

Sandoz Investments

No recent investments found related to Sandoz

These are all the companies that Sandoz has invested in. Sandoz has invested 4 companies and its latest investment was Cephalosporin Antibiotics Business, GlaxoSmithKline plc. in Feb 2021.

Sandoz News

May 21, 2021The Center for Biosimilar

Sandoz Panel Describes Issues, Opportunities for Biosimilars

Biosimilar education can increase physician motivation to prescribe these alternatives to costly orig... See more »
May 20, 2021Endpoints News

Novartis' Sandoz reshuffles antibiotic supply chain in EU as field faces a shortage of investment

While much of the focus in manufacturing has shifted away from antibiotics, a division of Novartis is... See more »
May 20, 2021CompanyNews HQ

US Supreme Court denies Sandoz petition to review biosimilar Erelzi (etanercept-szzs) case | Novartis

Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more af... See more »
May 18, 2021BioPharma-Reporter

Sandoz sees route to market with Enbrel biosimilar blocked for eight more years

Novartis subsidiary, Sandoz, says the US Supreme Court has denied its petition to review the Federal ... See more »
May 17, 2021FiercePharma

Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein

Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free re... See more »
May 7, 2021Powder and Bulk Solids

BASF to Boost Enzymes Production with Sandoz

The firm will invest in the Novartis subsidiary's site in Austria to expand production of bacterial e... See more »
May 4, 2021Clinical Trials Arena

Sandoz to study biosimilar aflibercept in Phase III AMD trial

The post Sandoz to study biosimilar aflibercept in Phase III AMD trial appeared first on Clinical Tri... See more »

Sandoz Press Releases

September 25, 2019WebWire

FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity

The U.S. Food and Drug Administration is alerting health care professionals and patients of a volunta... See more »
July 9, 2019GlobeNewswire

Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI

SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) provid... See more »
January 10, 2019WebWire

Sandoz and Pear Therapeutics Announce US Launch of reSET-OTM to Help Treat Opioid Use Disorder

Sandoz Inc., a Novartis division, and Pear Therapeutics, Inc., announced today the US commercial laun... See more »
December 18, 2018GlobeNewswire

Curetis' Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

Vienna, Austria, Holzgerlingen, Germany and Amsterdam, The Netherlands; December 18, 2018; published ... See more »
December 10, 2018StreetInsider

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder

Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital ... See more »
December 10, 2018StreetInsider

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder

Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital ... See more »
July 23, 2018MarketersMedia

DURECT Corporation, Near Term PDUFA Dates, Pipeline Review and Analysts Target

NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Traders News Source, a leading independent equity researc... See more »

Sandoz Videos

Social Media

Sandoz Headquarters

Industriestrasse 25

Holzkirchen, Bavaria83607

49-8024-476-0

Driving Directions »

Trending Companies

Sandoz Summary

ABOUT

Overview

Sandoz develops, manufactures and markets generic pharmaceutical products focused on biosimilars, injectables, inhalers and transdermal patches. Sandoz was founded in 1886. Sandoz's headquarters is located in Holzkirchen, Bavaria, DE 83607. Sandoz's ...

CEO

Sandoz's CEO, Richard Saynor, currently has an approval rating of 70%. Sandoz's primary competitors are Par Pharmaceutical, Ranbaxy & Sagent Pharmaceuticals.

Website

sandoz.com

Frequently Asked Questions about Sandoz

  1. When was Sandoz founded?

    Sandoz was founded in 1886
  2. Who is Sandoz's CEO?

    Sandoz's CEO is Richard Saynor
  3. How much revenue does Sandoz generate?

    Sandoz generates $9.6B in revenue
  4. How much funding does Sandoz have?

    Sandoz has historically raised $0 in funding
  1. Where is Sandoz's headquarters?

    Sandoz's headquarters is in Holzkirchen Bavaria, DE
  2. How many employees does Sandoz have?

    Sandoz has 26,500 employees
  3. What sector does Sandoz operate in?

    Sandoz is in Pharmaceuticals
  4. Who are Sandoz's competitors?

    Sandoz's top competitors are Par Pharmaceutical, Ranbaxy, Sagent Pharmaceuticals